Methodology of a new inflammatory arthritis registry: TReasure

Creative Commons License

KALYONCU U., Tascilar E. K., ERTENLİ A. İ., DALKILIÇ H. E., Bes C., KÜÇÜKŞAHİN O., ...Daha Fazla

TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.48, sa.4, ss.856-861, 2018 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 48 Sayı: 4
  • Basım Tarihi: 2018
  • Doi Numarası: 10.3906/sag-1807-200
  • Dergi Adı: TURKISH JOURNAL OF MEDICAL SCIENCES
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.856-861
  • Anahtar Kelimeler: Rheumatoid arthritis, spondyloarthritis, disease-modifying antirheumatic drugs, registry, TReasure, SOCIETY CLASSIFICATION CRITERIA, NECROSIS FACTOR THERAPY, RHEUMATOID-ARTHRITIS, ANKYLOSING-SPONDYLITIS, DISEASE-ACTIVITY, PSORIATIC-ARTHRITIS, DIAGNOSTIC-CRITERIA, BIOLOGICS REGISTER, CLINICAL HISTORY, BACK-PAIN
  • Akdeniz Üniversitesi Adresli: Evet

Özet

Background/aim: The TReasure registry, created in 2017, is an observational multicenter cohort that includes inflammatory arthritis patients. This article reviews the methodology and objectives of the TReasure registry established to collect data from rheumatoid arthritis (RA) and spondyloarthritis (SpA) patients.